冠状动脉疾病-话题@MedSci

#冠状动脉疾病#

125篇内容 | 5673人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1252904, encodeId=d0c912529048b, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Redox Biol：红细胞sGC/PDE-5/PKG功能性途径是冠状动脉疾病潜在药用靶标, objectType=article, longId=113589, objectId=da51113589f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da51113589f4, replyNumber=0, likeNumber=120, createdTime=2017-09-23, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da51113589f4, moduleTitle=Redox Biol：红细胞sGC/PDE-5/PKG功能性途径是冠状动脉疾病潜在药用靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da51113589f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252903, encodeId=c76712529032c, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=NAT COMMUN：冠状动脉疾病潜在靶标被发现, objectType=article, longId=113003, objectId=289111300315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=289111300315, replyNumber=0, likeNumber=91, createdTime=2017-09-18, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=289111300315, moduleTitle=NAT COMMUN：冠状动脉疾病潜在靶标被发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=289111300315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252902, encodeId=17b5125290273, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=ESC 2017：冠状动脉疾病双联抗血小板治疗指南, objectType=article, longId=111028, objectId=5f8c1110283d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f8c1110283d, replyNumber=0, likeNumber=64, createdTime=2017-08-29, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f8c1110283d, moduleTitle=ESC 2017：冠状动脉疾病双联抗血小板治疗指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f8c1110283d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252901, encodeId=21c51252901df, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=2017 ACR适宜性标准：慢性胸痛-高度冠状动脉疾病可能性, objectType=article, longId=110302, objectId=cfc511030277, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfc511030277, replyNumber=0, likeNumber=55, createdTime=2017-08-21, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfc511030277, moduleTitle=2017 ACR适宜性标准：慢性胸痛-高度冠状动脉疾病可能性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfc511030277)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252900, encodeId=736d125290045, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Redox Biol：SIRT1为冠状动脉疾病治疗提供新参考, objectType=article, longId=108907, objectId=a2d310890e8f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d310890e8f, replyNumber=0, likeNumber=73, createdTime=2017-08-17, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d310890e8f, moduleTitle=Redox Biol：SIRT1为冠状动脉疾病治疗提供新参考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d310890e8f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252899, encodeId=47bd12528990f, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Circulation：研究测定冠状动脉疾病风险位点GUCY1A3的功能, objectType=article, longId=108157, objectId=7b8110815e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b8110815e05, replyNumber=0, likeNumber=78, createdTime=2017-08-10, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b8110815e05, moduleTitle=Circulation：研究测定冠状动脉疾病风险位点GUCY1A3的功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b8110815e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252898, encodeId=4c1f125289819, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=JCLA：血管内皮生长因子+405C / G多态性对冠状动脉疾病长期预后及严重程度的影响, objectType=article, longId=106523, objectId=2e2c10652363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e2c10652363, replyNumber=0, likeNumber=70, createdTime=2017-07-26, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e2c10652363, moduleTitle=JCLA：血管内皮生长因子+405C / G多态性对冠状动脉疾病长期预后及严重程度的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e2c10652363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252897, encodeId=09be125289ec4, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Int J Cardiol：年龄对血小板与淋巴细胞比值与冠状动脉疾病之间相关性的调节作用!, objectType=article, longId=105145, objectId=389810514575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=389810514575, replyNumber=0, likeNumber=80, createdTime=2017-07-12, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=389810514575, moduleTitle=Int J Cardiol：年龄对血小板与淋巴细胞比值与冠状动脉疾病之间相关性的调节作用!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=389810514575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252896, encodeId=4f1a125289695, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Diabetologia：犬尿氨酸/色氨酸比值能预测冠状动脉疾病患者新发2型糖尿病, objectType=article, longId=102821, objectId=97e410282152, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97e410282152, replyNumber=0, likeNumber=98, createdTime=2017-06-23, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97e410282152, moduleTitle=Diabetologia：犬尿氨酸/色氨酸比值能预测冠状动脉疾病患者新发2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97e410282152)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252895, encodeId=45231252895a3, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Redox Biol ：SIRT1表达抑制或是冠状动脉疾病患者长期复发性缺血事件高风险的原因之一, objectType=article, longId=102817, objectId=811b10281e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=811b10281e6f, replyNumber=0, likeNumber=87, createdTime=2017-06-23, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=811b10281e6f, moduleTitle=Redox Biol ：SIRT1表达抑制或是冠状动脉疾病患者长期复发性缺血事件高风险的原因之一, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=811b10281e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252894, encodeId=91841252894cc, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Nat Genet：15个全新致病风险位点揭示冠状动脉疾病形成机制, objectType=article, longId=99732, objectId=06b499e326c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06b499e326c, replyNumber=0, likeNumber=58, createdTime=2017-05-27, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06b499e326c, moduleTitle=Nat Genet：15个全新致病风险位点揭示冠状动脉疾病形成机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06b499e326c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252893, encodeId=82b21252893f8, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Ciculation：如何降低牛皮癣患者冠状动脉疾病的发病率？, objectType=article, longId=98245, objectId=fd829824506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd829824506, replyNumber=0, likeNumber=149, createdTime=2017-05-10, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd829824506, moduleTitle=Ciculation：如何降低牛皮癣患者冠状动脉疾病的发病率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd829824506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252892, encodeId=f1c512528923d, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=JAHA：替卡格雷与氯吡格雷对冠状动脉疾病患者心肌灌注的疗效比较！, objectType=article, longId=98146, objectId=87fe98146d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87fe98146d7, replyNumber=0, likeNumber=115, createdTime=2017-05-10, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87fe98146d7, moduleTitle=JAHA：替卡格雷与氯吡格雷对冠状动脉疾病患者心肌灌注的疗效比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87fe98146d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252891, encodeId=f21a12528917c, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=JAHA：有症状糖尿病患者但无阻塞性冠状动脉疾病患者雷诺拉嗪疗效如何？, objectType=article, longId=98105, objectId=a233981053f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a233981053f, replyNumber=0, likeNumber=96, createdTime=2017-05-09, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a233981053f, moduleTitle=JAHA：有症状糖尿病患者但无阻塞性冠状动脉疾病患者雷诺拉嗪疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a233981053f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252890, encodeId=bd3e125289045, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Lancet Diabetes Endo：载脂蛋白A亚型、脂蛋白A浓度和冠状动脉疾病, objectType=article, longId=95444, objectId=18e6954449c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18e6954449c, replyNumber=0, likeNumber=68, createdTime=2017-04-13, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18e6954449c, moduleTitle=Lancet Diabetes Endo：载脂蛋白A亚型、脂蛋白A浓度和冠状动脉疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18e6954449c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252889, encodeId=d14c1252889ef, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Allergy：冠状动脉疾病患者：阿司匹林激发和/或脱敏的合格临床标准, objectType=article, longId=93146, objectId=ce9593146e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce9593146e6, replyNumber=0, likeNumber=65, createdTime=2017-03-25, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce9593146e6, moduleTitle=Allergy：冠状动脉疾病患者：阿司匹林激发和/或脱敏的合格临床标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce9593146e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252888, encodeId=574f1252888b6, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Am J Cardiol: 外周动脉疾病合并冠状动脉疾病的患者，预后不良, objectType=article, longId=92895, objectId=4c379289571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c379289571, replyNumber=0, likeNumber=61, createdTime=2017-03-24, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c379289571, moduleTitle=Am J Cardiol: 外周动脉疾病合并冠状动脉疾病的患者，预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c379289571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252887, encodeId=5581125288e35, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=JAMA：LPL基因突变与冠状动脉疾病相关！, objectType=article, longId=91178, objectId=3915911e887, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3915911e887, replyNumber=0, likeNumber=100, createdTime=2017-03-10, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3915911e887, moduleTitle=JAMA：LPL基因突变与冠状动脉疾病相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3915911e887)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252886, encodeId=e3de125288646, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=Heart：对生物可吸收血管支架和药物洗脱支架治疗冠状动脉疾病的二年预后比较, objectType=article, longId=88118, objectId=2a7588118e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a7588118e9, replyNumber=0, likeNumber=89, createdTime=2017-01-28, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a7588118e9, moduleTitle=Heart：对生物可吸收血管支架和药物洗脱支架治疗冠状动脉疾病的二年预后比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a7588118e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1252885, encodeId=dad3125288511, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, objectTitle=【盘点】近期冠状动脉疾病重大研究进展一览, objectType=article, longId=83499, objectId=5de683499e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5de683499e0, replyNumber=0, likeNumber=77, createdTime=2016-12-05, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5de683499e0, moduleTitle=【盘点】近期冠状动脉疾病重大研究进展一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5de683499e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

冠状动脉疾病

2020-05-29

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Redox Biol：红细胞sGC/PDE-5/PKG功能性途径是冠状动脉疾病潜在药用靶标

2017-09-23

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

NAT COMMUN：冠状动脉疾病潜在靶标被发现

2017-09-18

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

ESC 2017：冠状动脉疾病双联抗血小板治疗指南

2017-08-29

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

2017 ACR适宜性标准：慢性胸痛-高度冠状动脉疾病可能性

2017-08-21

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Redox Biol：SIRT1为冠状动脉疾病治疗提供新参考

2017-08-17

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Circulation：研究测定冠状动脉疾病风险位点GUCY1A3的功能

2017-08-10

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

JCLA：血管内皮生长因子+405C / G多态性对冠状动脉疾病长期预后及严重程度的影响

2017-07-26

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Int J Cardiol：年龄对血小板与淋巴细胞比值与冠状动脉疾病之间相关性的调节作用!

2017-07-12

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Diabetologia：犬尿氨酸/色氨酸比值能预测冠状动脉疾病患者新发2型糖尿病

2017-06-23

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Redox Biol ：SIRT1表达抑制或是冠状动脉疾病患者长期复发性缺血事件高风险的原因之一

2017-06-23

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Nat Genet：15个全新致病风险位点揭示冠状动脉疾病形成机制

2017-05-27

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Ciculation：如何降低牛皮癣患者冠状动脉疾病的发病率？

2017-05-10

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

JAHA：替卡格雷与氯吡格雷对冠状动脉疾病患者心肌灌注的疗效比较！

2017-05-10

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

JAHA：有症状糖尿病患者但无阻塞性冠状动脉疾病患者雷诺拉嗪疗效如何？

2017-05-09

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Lancet Diabetes Endo：载脂蛋白A亚型、脂蛋白A浓度和冠状动脉疾病

2017-04-13

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Allergy：冠状动脉疾病患者：阿司匹林激发和/或脱敏的合格临床标准

2017-03-25

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Am J Cardiol: 外周动脉疾病合并冠状动脉疾病的患者，预后不良

2017-03-24

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

JAMA：LPL基因突变与冠状动脉疾病相关！

2017-03-10

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

Heart：对生物可吸收血管支架和药物洗脱支架治疗冠状动脉疾病的二年预后比较

2017-01-28

howi (审核中...)

前往app查看评论内容

#冠状动脉疾病#

【盘点】近期冠状动脉疾病重大研究进展一览

2016-12-05

科室
- - 订阅+
  - 更多科室
工具
服务